Investor Relations 5DOK SI

nutrients - PPM GUMed

Protected

N/A

20

0

2024

Complementary and Alternative Therapies in Oncology

Protected

N/A

16

0

2024

Up-regulation of PCSK9 gene expression and diminished level of LDL-receptor in rat liver as a potential cause of post-lipectomy hypercholesterolemia

Protected

N/A

12

0

2024

How to deal with the occurrence of rare drug-induced adverse events: the example of sprue-likeenteropathy induced by olmesartan medoxomiland other angiotensin-receptor blockers

Protected

N/A

4

0

2024

Different Faces of Fas Signaling in Cancer Cells - PPM GUMed

Protected

N/A

4

0

2024

Concentrations of Cardiovascular Biomarkers

Protected

N/A

11

0

2024

Pobrano z Repozytorium Gdańskiego Uniwersytetu Medycznego / Downloaded from Repository of Medical Univeristy of Gdańsk 2023-07-27

Protected

N/A

16

0

2024

Does the age of patients with heredi-tary hemochromatosis at the moment of their first diagnosis have an additio-nal effect on the standard echocardio-graphic parameters?

Protected

N/A

6

0

2024

$1.Introduction MarcinFija ł kowski, andMaciejJankowski JoannaMarl ę ga, Agnieszka Ć wikli ń ska, MilenaPaprzycka, MarcinGrucha ł a, AgnieszkaMickiewicz, EwelinaKreft, AgnieszkaKuchta, EwaWieczorek, TheImpactofLipoproteinApheresisonOxidativeStressBiomarkersandHigh-DensityLipoproteinSubfractions ResearchArticle$

1.Introduction MarcinFija ł kowski, andMaciejJankowski JoannaMarl ę ga, Agnieszka Ć wikli ń ska, MilenaPaprzycka, MarcinGrucha ł a, AgnieszkaMickiewicz, EwelinaKreft, AgnieszkaKuchta, EwaWieczorek, TheImpactofLipoproteinApheresisonOxidativeStressBiomarkersandHigh-DensityLipoproteinSubfractions ResearchArticle

Protected

N/A

7

0

2024

Dosimetrically administered nebulized morphine for ... - PPM GUMed

Protected

N/A

9

0

2024

Naložbena razmerja

Nov dokument